Prophylactics of Osteoporosis
,
Abstract
No Abstract
1. Borissova AM (1998). Osteoporosis-Diagnostic, Prevention and Treatment. Endocrinolagia, 3 (4): 59.
2. Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi U, et al (2012). Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary. Arch Osteoporos, 7 (1–2): 3–20.
3. Ivanova S. Regulatory aspects of osteo-porosis treatment and analytical char-acteristics of certain steroid-structured medicinal products. [PhD thesis]. Medical University - Plovdiv, Plovdiv; 2015.
4. Becheva M (2019). A Textbook on Kine-sitherapy. Medical University Publish-ing House. Plovdiv, ISBN 978-619-237-037-4, p. 517.
5. Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, Reid IR (2015). Calcium intake and risk of fracture: sys-tematic review. BMJ, 351: h4580.
6. Papadimitropoulos E, Wells G, Shea B, et al (2002). Meta-analysis of the efficacy of vitamin D treatment in preventing osteo-porosis in postmenopausal women. En-docr Rev, 23: 560–69.
7. Marjoribanks J, Farquhar C, Roberts H, Lethaby A (2012). Long term hormone therapy for perimenopausal and post-menopausal women. Cochrane Database Syst Rev, (7): CD004143.
8. Kanis JA, Johnell O, Oden A, et al (2005). Smoking and fracture risk: a meta-analysis. Osteoporos Int, 216: 155–62.
9. Tsvetkova D, Obreshkova D, Ivanova S, Hadjieva B (2017). Evaluation of separa-tion of steroids in combined forms by RP HPLC with UV-detection and gas chromatography. Bulg Chem Commun, 49(2): 377-83.
10. Kanis JA, Oden A, Johnell O, et al (2007). The use of clinical risk factors enhances the performance of BMD in the predic-tion of hip and osteoporotic fractures in men and women. Osteoporos Int, 18: 1033–46.
2. Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi U, et al (2012). Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary. Arch Osteoporos, 7 (1–2): 3–20.
3. Ivanova S. Regulatory aspects of osteo-porosis treatment and analytical char-acteristics of certain steroid-structured medicinal products. [PhD thesis]. Medical University - Plovdiv, Plovdiv; 2015.
4. Becheva M (2019). A Textbook on Kine-sitherapy. Medical University Publish-ing House. Plovdiv, ISBN 978-619-237-037-4, p. 517.
5. Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, Reid IR (2015). Calcium intake and risk of fracture: sys-tematic review. BMJ, 351: h4580.
6. Papadimitropoulos E, Wells G, Shea B, et al (2002). Meta-analysis of the efficacy of vitamin D treatment in preventing osteo-porosis in postmenopausal women. En-docr Rev, 23: 560–69.
7. Marjoribanks J, Farquhar C, Roberts H, Lethaby A (2012). Long term hormone therapy for perimenopausal and post-menopausal women. Cochrane Database Syst Rev, (7): CD004143.
8. Kanis JA, Johnell O, Oden A, et al (2005). Smoking and fracture risk: a meta-analysis. Osteoporos Int, 216: 155–62.
9. Tsvetkova D, Obreshkova D, Ivanova S, Hadjieva B (2017). Evaluation of separa-tion of steroids in combined forms by RP HPLC with UV-detection and gas chromatography. Bulg Chem Commun, 49(2): 377-83.
10. Kanis JA, Oden A, Johnell O, et al (2007). The use of clinical risk factors enhances the performance of BMD in the predic-tion of hip and osteoporotic fractures in men and women. Osteoporos Int, 18: 1033–46.
| Files | ||
| Issue | Vol 49 No 12 (2020) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v49i12.4834 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
IVANOVA S, KIRKOVA-BOGDANOVA A, VAKRILOVA BECHEVA M. Prophylactics of Osteoporosis. Iran J Public Health. 2020;49(12):2426-2427.
